Liver Cancer Global Clinical Trials Review, H2, 2013
Dec 19, 2013, 01:44 ET
NEW YORK, Dec. 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Liver Cancer Global Clinical Trials Review, H2, 2013
Liver Cancer Global Clinical Trials Review, H2, 2013
Summary
GlobalData's clinical trial report, "Liver Cancer Global Clinical Trials Review, H2, 2013" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Liver Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Liver Cancer 23
Subjects Recruited Over a Period of Time 39
Prominent Sponsors 40
Top Companies Participating in Liver Cancer Therapeutics Clinical Trials 42
Prominent Drug Comparison 44
Clinical Trial Profiles 45
Clinical Trial Overview of Top Companies 45
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
F. Hoffmann-La Roche Ltd. 49
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 49
Pfizer Inc. 51
Clinical Trial Overview of Pfizer Inc. 51
Novartis AG 53
Clinical Trial Overview of Novartis AG 53
Sanofi 55
Clinical Trial Overview of Sanofi 55
Bristol-Myers Squibb Company 57
Clinical Trial Overview of Bristol-Myers Squibb Company 57
Eli Lilly and Company 59
Clinical Trial Overview of Eli Lilly and Company 59
Sirtex Medical Limited 60
Clinical Trial Overview of Sirtex Medical Limited 60
AstraZeneca PLC 61
Clinical Trial Overview of AstraZeneca PLC 61
Clinical Trial Overview of Top Institutes / Government 62
National Cancer Institute 62
Clinical Trial Overview of National Cancer Institute 62
Eastern Hepatobiliary Surgery Hospital 71
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 71
The University of Texas M. D. Anderson Cancer Center 75
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 75
Sun Yat-sen University 78
Clinical Trial Overview of Sun Yat-sen University 78
Memorial Sloan Kettering Cancer Center 81
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 81
FUDAN University 83
Clinical Trial Overview of FUDAN University 83
National Taiwan University Hospital 85
Clinical Trial Overview of National Taiwan University Hospital 85
Massachusetts General Hospital 87
Clinical Trial Overview of Massachusetts General Hospital 87
Stanford University 89
Clinical Trial Overview of Stanford University 89
National Cancer Center Hospital 90
Clinical Trial Overview of National Cancer Center Hospital 90
Five Key Clinical Profiles 91
Appendix 172
Abbreviations 172
Definitions 172
Research Methodology 173
Secondary Research 173
About GlobalData 174
Contact Us 174
Disclaimer 174
Source 175
List of Tables
Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Liver Cancer Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2013* 16
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2013* 18
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 39
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 41
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 43
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 44
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 45
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 49
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 51
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 53
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 55
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 57
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 59
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sirtex Medical Limited, 2013* 60
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 61
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2013* 62
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2013* 71
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2013* 75
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2013* 78
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 81
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2013* 83
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 85
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 87
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 89
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2013* 90
List of Figures
Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Liver Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 39
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 40
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 42
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 44
GlobalData Methodology 173
To order this report: Liver Cancer Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0704005/Liver-Cancer-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker